Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Feb 5, 2026
Date Accepted: Sep 18, 2026

The final, peer-reviewed published version of this preprint can be found here:

Psychosocial Distress and Radiation Treatment Interruptions in Patients With Cancer Using Machine Learning and Regression: Retrospective Cohort Study

Hashtarkhani S, Brett CL, Kumsa FA, Rashid R, Kheirkhah Rahimabad P, Kheirinejad S, Davis RL, Schwartz DL, Shaban-Nejad A

Psychosocial Distress and Radiation Treatment Interruptions in Patients With Cancer Using Machine Learning and Regression: Retrospective Cohort Study

JMIR Cancer 2026;12:e92899

DOI: 10.2196/92899

PMID: 42896154

Psychosocial Distress and Risk of Radiation Treatment Interruptions in Cancer Patients: Retrospective Cohort Study Using Machine Learning and Regression Modeling

  • Soheil Hashtarkhani; 
  • Christopher L Brett; 
  • Fekede Asefa Kumsa; 
  • Rezaur Rashid; 
  • Parnian Kheirkhah Rahimabad; 
  • Saba Kheirinejad; 
  • Robert L Davis; 
  • David L Schwartz; 
  • Arash Shaban-Nejad

ABSTRACT

Background:

Uninterrupted delivery of radiation therapy is critical to cancer treatment quality. Unplanned radiation treatment interruptions (RTI) compromise tumor control and survival. Although previous studies have explored clinical and sociodemographic factors influencing treatment adherence, the role of psychosocial distress and related symptoms remains unclear

Objective:

To identify patient-reported psychosocial predictors of RTI from patient-reported distress screening data integrated with clinical and socioeconomic correlates via traditional and machine learning-enhanced modeling

Methods:

This institutional cohort study included 1,953 patients who underwent external beam radiation therapy between August 2020 and May 2024. Patient demographics, clinical characteristics, treatment details, and baseline distress levels were extracted from a hospital-level electronic health record (EHR) data repository. Distress was assessed using the Distress Thermometer developed by the National Comprehensive Cancer Network (NCCN). These data were linked with census tract–level socioeconomic indicators. Predictors of treatment interruption (measured as missed treatment days) were evaluated using negative binomial regression and an Extreme Gradient Boosting (XGBoost) model with a Poisson objective function

Results:

The study cohort missed a mean of 1.19 ± 2.18 treatment days (range: 0–15). Higher distress score, presence of learning or communication barriers, and specific cancer sites—particularly head and neck and genitourinary malignancies—were significantly associated with increased interruption risk in the negative binomial regression model. The XGBoost model confirmed these features as top contributors to prediction performance, while yielding an incrementally lower root mean squared error of 2.20 (versus 2.24 for the regression model)

Conclusions:

Patient-reported distress and health educational barriers strongly associate with treatment interruptions, underscoring the importance of incorporating psychosocial assessments into radiation oncology workflows. Both parametric and machine learning models provided stable and closely aligned predictions of missed radiation treatment days. Combining traditional regression and machine learning approaches improved interpretability and predictive accuracy, supporting continued integration of complementary modeling into the development of early intervention strategies to enhance treatment adherence


 Citation

Please cite as:

Hashtarkhani S, Brett CL, Kumsa FA, Rashid R, Kheirkhah Rahimabad P, Kheirinejad S, Davis RL, Schwartz DL, Shaban-Nejad A

Psychosocial Distress and Radiation Treatment Interruptions in Patients With Cancer Using Machine Learning and Regression: Retrospective Cohort Study

JMIR Cancer 2026;12:e92899

DOI: 10.2196/92899

PMID: 42896154

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.